Journal of Global Antimicrobial Resistance (Dec 2020)

Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones

  • B. Davido,
  • L. Noussair,
  • A. Saleh-Mghir,
  • E. Salomon,
  • F. Bouchand,
  • M. Matt,
  • C. Lawrence,
  • T. Bauer,
  • J.L. Herrmann,
  • C. Perronne,
  • J.L. Gaillard,
  • M. Rottman,
  • A. Dinh

Journal volume & issue
Vol. 23
pp. 74 – 78

Abstract

Read online

Objectives: Limited data have been reported regarding osteomyelitis due to carbapenemase-producing Enterobacteriaceae (CPE), including co-infections with extended-spectrum β-lactamase (ESBL)-producing micro-organisms. Methods: We conducted a retrospective study in a reference centre for bone and joint infections from 2011 to 2019 among patients infected with CPE. Results: Nine patients (mean age 46.8 ± 16.6 years), including three with infected implants, were identified. Infections were mostly polymicrobial (n = 8/9), including Staphylococcus aureus (n = 6/9). CPE were mainly OXA-48-type, associated with ESBL-producing Enterobacteriaceae (n = 8/9), of which 5/9 isolates were Klebsiella pneumoniae. Control of the infection was achieved in seven cases. Conclusions: CPE osteomyelitides are essentially polymicrobial and fluoroquinolone-resistant infections, highlighting the need for efficient surgery with implant removal.

Keywords